Statistics
Publications
2
Citations
37
H-Index
2
Active since
2021
Bin Luo is an author at Novo Nordisk (Denmark) specializing in clinical pharmacology, oral antidiabetic therapy, and diabetes control.
Publications per year
2021–2022
2
2
Pei Yu, Bue Ross Agner, Bin Luo et al. · Diabetes Obesity and Metabolism · 2021 · 21 citations · Full text
Weiqing Wang, Bue F. Ross Agner, Bin Luo et al. · Journal of Diabetes · 2022 · 16 citations · Full text
1–2 of 2